Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours

British Journal of Cancer

Volumn 87, Issue 1, 2002, Pages 86-90

  Hall, G H ^a   Turnbull, L W ^a   Richmond, I ^b   Helboe, L ^c   Atkin, S L ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

^c H LUNDBECK A S   (Denmark)

Author keywords

Angiogenesis; Immunohistochemistry; Ovarian cancer; Somatostatin; Somatostatin receptors

Indexed keywords

HORMONE ANTAGONIST; HORMONE RECEPTOR STIMULATING AGENT; SOMATOSTATIN; SOMATOSTATIN ANTAGONIST; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; RECEPTOR BINDING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN DISEASES; OVARIAN NEOPLASMS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

EID: 0036649145     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600284     Document Type: Article

References (31)

1. Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis
2. Feasibility, endocrine and anti-tumor effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an anti-prolactin in postmenopausal metastatic breast cancer: A randomised study with long-term follow-up
3. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2
4. Somatostatin receptor subtype expression and function in human vascular tissue
5. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: A primary role for tyrosine phosphatase SHP-1
6. Somatostatin inhibits PC C13 thyroid cell proliferation through the modulation of phosphotyrosine activity. Impairment of the somatostatinergic effects by stable expression of the E1A viral oncogene
7. Human ovarian cancers express somatostatin receptors
8. 5
9. Somatostatin in human follicular-fluid
10. Classification and nomenclature of somatostatin receptors
11. Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells
12. Phase II study of RC-160 (vapreotide), octapeptide analogue of somatostatin, in the treatment of breast cancer
13. In vivo neutralisation of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) inhibits ovarian carcinoma-associated ascites formation and tumor growth
14. Macrophages and microvessel density in tumors of the ovary
15. Vascular endothelial growth factor expression in early stage ovarian carcinoma
16. Postreceptor signal transduction mechanisms involved in octreotide-induced inhibition of angiogenesis
17. Somatostatin and its receptor family
18. Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN-238
19. Mechanisms of antineoplastic action of somatostatin analogs
20. A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth
21. Somatostatin receptors in differentiated ovarian tumors
22. Somatostatin (SRIF) messenger ribonucleic acid expression in human neuroendocrine and brain tumours using in situ hybridisation histochemistry: Comparison with SRIH receptor content
23. High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumour-host interaction?
24. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels
25. Subtype-selective induction of wildtype p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3
26. Neuro-hormonal peptides in ovarian carcinoids - An immunohistochemical study of 81 primary carcinoids and of intra-ovarian metastases from 6 midgut carcinoids
27. Human somatostatin receptor mediated antiproliferative action evokes subtype selective cytotoxic and cytostatic signalling
28. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7, 12-dimethylbenz(a)anthracene-induced rat mammary carcinomas
29. Inhibition of human epithelial ovarian cancer cell growth in vitro by somatostatin analog RC-160
30. Synergy between angiostatin and endostatin: Inhibition of ovarian cancer growth